Article

Putting some teeth in cancer issues

Author(s):

It's always fun for me to get a call from a former student from my tenure at Southern Methodist University. Such was the case last fall when I got a call from a young man named Norberto Diaz, who had been my student more than a decade ago. Come to find out he had taken a new job, and, while he had called to catch up, he was also calling to tell me about his new job with a Dallas dentist named Dennis Abbott whose specialty is working with oncology patients. Of course, he knew my history, and he knew I was working at a cancer publication. When he began telling me about what Dr. Abbott was doing, I was intrigued. We had never done a story on dental issues around treatment, but I still could recall the pain of oral mucositis during my treatment. For days I walked around with a mouth full of liquid pain killer. Back then they had little to offer me but pain killer. Today Dr. Abbott has much more for his patients. It turns out that dental issues are huge for head and neck cancer patients as well as those who have problems with their teeth before starting any kind of therapy. We did a story on dental issues in our winter issue and had a number of readers say something along the lines of, "it's about time you talked about dental issues." So, we are going to do it again. This time in a facebook chat – tomorrow, April 12, at noon on our facebook page. Come join us and talk directly to Dr. Abbott about your dental issues.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content